Partnership will pursue cellular therapies for hard-to-treat wounds

04/9/2012 | Pharmaceutical Business Review Online

The human-based protein Elastatropin and technology involving adipose-derived stem cells and stromal cell culture media will be used to develop cellular treatments for wound healing and regenerative therapies. American CryoStem and Protein Genomics have formed a partnership that will focus on therapies for difficult-to-treat conditions.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA